| 17:35 | Registration |
|---|---|
| 18:15 | Opening Remarks Masakazu Toi |
| 18:20 | Seminar 1 Chemotherapy for early stage breast cancer -present and future prospect (Co-organiser: sanofi-aventis K.K.) Lecturer: Stephen Jones, Chair: Takashi Inamoto |
| 19:00 | Seminar 2 Novel biomarkers of anthracycline benefit in adjuvant breast cancer (Co-organiser: Pfizer Japan Inc.) Lecturer: John Bartlett, Chair: Hironobu Sasano |
| 9:00 | Consensus Session: Preoperative chemotherapy Chairs: Tomoharu Sugie and Hiroshi Ishiguro, Presentors: Hironobu Sasano and Shinji Ohno, Panelists: John Bartlett, Hidetaka Kawabata, Shinji Ohno and Hironobu Sasano |
|---|---|
| 11:00 | Coffee Break |
| 11:20 | Seminar 3 Neoadjuvant antihormonal therapy of breast cancer: state of the art and future options (Co-organiser: Novartis Pharma K.K.) Lecturer: Jürgen Geisler, Chair: Nobuaki Sato |
| 12:00 | Luncheon Seminar(*): Role of molecular targeting therapy for metastatic breast cancer (Co-organiser: Chugai Pharmaceutical Co.,Ltd) (*)Lecture: about 40 minutes Lecturer: Nicholas Robert, Chair: Shinji Ohno |
| 13:30 | Special Consensus Session: Evaluation of endocrine therapy before surgery (Co-organiser: AstraZeneca K.K.) Chairs: Mitsuhiro Tozaki and Shotaro Kanao, Presentors: Norikazu Masuda and Takayuki Ueno, Panelists: Masahiro Kashiwaba, Takahiro Nakayama, Norikazu Masuda and Takayuki Ueno |
| 15:30 | Closing Remarks Akira Yamauchi |